SRTOY (Sartorius Stedim Biotech) E10: $0.47 (As of Mar. 2026)


SRTOY Sartorius Stedim Biotech SA SRTOY
82 GF Score
Price $19.52
GF Value $23.93
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sartorius Stedim Biotech E10?

Sartorius Stedim Biotech SRTOY -3.34% 82 E10 is $0.47 as of Mar. 2026. GuruFocus rates SRTOY with a GF Score™ of 82/100 and a GF Value™ of $23.93 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sartorius Stedim Biotech's adjusted earnings per share data for the three months ended in Mar. 2026 was $0.105. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.47 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Sartorius Stedim Biotech's average E10 Growth Rate was 3.10% per year. During the past 3 years, the average E10 Growth Rate was 2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Sartorius Stedim Biotech was 2.90% per year. The lowest was 2.90% per year. And the median was 2.90% per year.

As of today (2026-06-26), Sartorius Stedim Biotech's current stock price is $19.515. Sartorius Stedim Biotech's E10 for the quarter that ended in Mar. 2026 was $0.47. Sartorius Stedim Biotech's Shiller PE Ratio of today is 41.52.

During the past 13 years, the highest Shiller PE Ratio of Sartorius Stedim Biotech was 120.93. The lowest was 37.37. And the median was 52.06.


Sartorius Stedim Biotech  (OTCPK:SRTOY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sartorius Stedim Biotech's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=19.515/0.47
=41.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sartorius Stedim Biotech was 120.93. The lowest was 37.37. And the median was 52.06.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sartorius Stedim Biotech E10 Related Terms


Sartorius Stedim Biotech E10 Historical Data

* Premium members only.

The historical data trend for Sartorius Stedim Biotech's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius Stedim Biotech E10 Chart

Sartorius Stedim Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.38 0.44 0.41 0.45

Sartorius Stedim Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.45 0.48 0.51 0.45 0.47

SRTOY vs ISRG, BDX, MDLN: E10 Comparison

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius Stedim Biotech Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's Shiller PE Ratio falls into.


SRTOY
82GF Score
Sartorius Stedim Biotech SA SRTOY
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sartorius Stedim Biotech E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sartorius Stedim Biotech's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.105/131.2583*131.2583
=0.105

Current CPI (Mar. 2026) = 131.2583.

Sartorius Stedim Biotech Quarterly Data

per share eps CPI Adj_EPS
201506 0.039 100.417 0.051
201512 0.000 99.717 0.000
201606 0.048 100.717 0.063
201612 0.000 101.217 0.000
201706 0.047 102.117 0.060
201709 0.048 102.717 0.061
201712 0.058 102.617 0.074
201803 0.054 102.917 0.069
201806 0.063 104.017 0.079
201809 0.063 104.718 0.079
201812 0.084 104.217 0.106
201903 0.069 104.217 0.087
201906 0.079 105.718 0.098
201909 0.069 106.018 0.085
201912 0.066 105.818 0.082
202003 0.090 105.718 0.112
202006 0.081 106.618 0.100
202009 0.127 105.818 0.158
202012 0.125 105.518 0.155
202103 0.162 107.518 0.198
202106 0.194 108.486 0.235
202109 0.189 109.435 0.227
202112 -0.010 110.384 -0.012
202203 0.323 113.968 0.372
202206 0.246 115.760 0.279
202209 0.216 118.818 0.239
202212 0.219 119.345 0.241
202303 0.130 122.402 0.139
202306 0.156 123.140 0.166
202309 0.039 124.195 0.041
202312 0.038 123.773 0.040
202403 0.063 125.038 0.066
202406 0.054 125.882 0.056
202409 0.029 126.198 0.030
202412 0.049 127.041 0.051
202503 0.095 127.779 0.098
202506 0.080 128.412 0.082
202509 0.077 129.255 0.078
202512 0.057 129.361 0.058
202603 0.105 131.258 0.105

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.47 mean?
Sartorius Stedim Biotech (SRTOY) has a E10 of $0.47 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sartorius Stedim Biotech and its competitors.
Is Sartorius Stedim Biotech's E10 too high?
Sartorius Stedim Biotech's current E10 is $0.47. Overall, Sartorius Stedim Biotech has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sartorius Stedim Biotech's E10 compare to ISRG and BDX?
Sartorius Stedim Biotech's E10 of $0.47 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Sartorius Stedim Biotech and its competitors. Sartorius Stedim Biotech's current E10 is $0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sartorius Stedim Biotech stock overvalued right now?
Based on GuruFocus' analysis, Sartorius Stedim Biotech (SRTOY) is currently considered Modestly Undervalued. The stock's GF Value™ is $23.93, compared to a current price of $19.52 — trading 18.4% below its estimated fair value. The current E10 is $0.47. Sartorius Stedim Biotech's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Sartorius Stedim Biotech (SRTOY), the current E10 is $0.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sartorius Stedim Biotech (SRTOY) Overvalued in 2026?

Based on GuruFocus' analysis, Sartorius Stedim Biotech stock appears to be undervalued. The current stock price of $19.52 is trading 18.4% below its estimated GF Value™ of $23.93. GuruFocus considers Sartorius Stedim Biotech to be Modestly Undervalued.

Key valuation signals for SRTOY:

  • E10: $0.47
  • GF Value™: $23.93 vs. price of $19.52 (18.4% below fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the SRTOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sartorius Stedim Biotech Business Description

Address Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. It sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.
82GF Score

Get the complete analysis for SRTOY

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.52
Price
$23.93
GF Value